🇺🇸 FDA
Pipeline program

Liposome bupivacaine + bupivacaine

1601

Phase 2 small_molecule completed

Quick answer

Liposome bupivacaine + bupivacaine for Dupuytren's Contracture of the Hand (Viking's Disease) is a Phase 2 program (small_molecule) at Pacira BioSciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Pacira BioSciences
Indication
Dupuytren's Contracture of the Hand (Viking's Disease)
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials